Cyper Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.43 M
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 5.00 M
- Satisfied Charges ₹ 2.00 M
About Cyper Drugs And Pharmaceuticals
Cyper Drugs And Pharmaceuticals Private Limited (CDAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 April 1997 and has a history of 27 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.43 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajni Bhargava and Nandita Bhargava serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397DL1997PTC086799
- Company No.
086799
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 1997
- Date of AGM
30 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cyper Drugs And Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajni Bhargava  | Director | 30-Aug-2003 | Current |
| Nandita Bhargava | Director | 22-Apr-1997 | Current |
Financial Performance of Cyper Drugs And Pharmaceuticals.
Enhance accessibility to Cyper Drugs And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cyper Drugs And Pharmaceuticals?
Unlock access to Cyper Drugs And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.00 M
₹2.00 M
Charges Breakdown by Lending Institutions
- State Bank Of Bikaner & Jaipur : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 2006 | State Bank Of Bikaner & Jaipur | ₹5.00 M | Open |
| 19 Apr 2000 | Punjab & Sind Bank | ₹1.00 M | Satisfied |
| 15 Sep 1997 | Delhi Financial Corporation | ₹1.00 M | Satisfied |
How Many Employees Work at Cyper Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Cyper Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cyper Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyper Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.